There are 116 resources available
Risk of Recurrence in Patients With HR+/HER2− Early Breast Cancer
Presenter: César A. Rodríguez
Session: Novartis - The Evolution of HR+/HER2− Early Breast Cancer Clinical Practice: Broadening the Impact of CDK4/6 Inhibitors
Resources:
Webcast
KRASG12C inhibitors: expanding outcomes from clinical studies to real-world patient populations
Presenter: Melissa Johnson
Session: Amgen - Innovation in lung cancer treatment: unlocking the potential of precision medicine
Resources:
Webcast
Evolving Standards: Maximizing Outcomes in Advanced HCC with Immunotherapy
Presenter: Lorenza Rimassa
Session: Medscape Global Oncology - Milestones and Horizons in Hepatobiliary Carcinomas: The Unfolding Story of Immunotherapy
Resources:
Webcast
Detecting targets early: biomarkers and testing in lung cancer
Presenter: Fernando Lopez-Rios
Session: F. Hoffmann - La Roche - Patient Matters: Innovation in Lung Cancer
Resources:
Webcast
Treating HER2- and HR-Positive Breast Cancers: An Era of Impressive Advances
Presenter: Peter Schmid
Session: PeerVoice - Staying at the Forefront of HER2- and TROP2-Directed Antibody-Drug Conjugate (ADC) Advances in Breast Cancer
Resources:
Webcast
Efficacy of CDK4/6 inhibitors in Patients With HR+/HER2− Early Breast Cancer
Presenter: Sara Tolaney
Session: Novartis - The Evolution of HR+/HER2− Early Breast Cancer Clinical Practice: Broadening the Impact of CDK4/6 Inhibitors
Resources:
Webcast
Engaging T cells in SCLC: the DLL3-targeted approach
Presenter: Anne-Marie Dingemans
Session: Amgen - Innovation in lung cancer treatment: unlocking the potential of precision medicine
Resources:
Webcast
Crafting the Future: Emerging Multimodal Strategies for Embolization-Eligible HCC
Presenter: Bruno Sangro
Session: Medscape Global Oncology - Milestones and Horizons in Hepatobiliary Carcinomas: The Unfolding Story of Immunotherapy
Resources:
Webcast
Targeting NSCLC: new developments in ALK+ and KRAS G12C NSCLC
Presenter: Ben Solomon, Jarushka Naidoo
Session: F. Hoffmann - La Roche - Patient Matters: Innovation in Lung Cancer
Resources:
Webcast
The Next Advances in ADC Strategies for HER2-Positive Metastatic Breast Cancer
Presenter: Cristina Saura Manich
Session: PeerVoice - Staying at the Forefront of HER2- and TROP2-Directed Antibody-Drug Conjugate (ADC) Advances in Breast Cancer
Resources:
Webcast